ヘリオス (Healios) とアサーシス (Athersys)、マルチステム (MultiStem®) 療法を使った 脳卒中治療において再生医療のパートナーシップを結ぶ
12. Januar 2016 15:16 ET
|
Athersys, Inc.
米国クリーブランド、東京, Jan. 13, 2016 (GLOBE NEWSWIRE) -- 株式会社ヘリオス (Healios K.K.、以下「ヘリオス」、東京株式取引所4593) とアサーシス社 (Athersys, Inc.、以下「アサーシス」) (NASDAQ:ATHX) は、虚血性脳卒中及びその他の適応症の治療のために、日本においてマルチステム (MultiStem®)...
Healios and Athersys Enter Into Regenerative Medicine Partnership for Treatment of Stroke Using MultiStem® Therapy
08. Januar 2016 06:00 ET
|
Athersys, Inc.
CLEVELAND and TOKYO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Healios K.K. (“Healios”) (Tokyo Stock Exchange: 4593) and Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) have announced a partnership and license...
Healios and Athersys Enter Into Regenerative Medicine Partnership for Treatment of Stroke Using MultiStem® Therapy
08. Januar 2016 03:00 ET
|
Athersys, Inc.
CLEVELAND and TOKYO, Jan. 08, 2016 (GLOBE NEWSWIRE) -- Healios K.K. (“Healios”) (Tokyo Stock Exchange:4593) and Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) have announced a partnership and license...
Athersys to Present at Biotech Showcase(TM) 2016
04. Januar 2016 13:30 ET
|
Athersys, Inc.
CLEVELAND, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and Chief Executive Officer, will present at the Biotech ShowcaseTM 2016...
Athersys’ MultiStem® Promotes Recovery After Acute Spinal Cord Injury in Preclinical Study
19. November 2015 05:36 ET
|
Athersys, Inc.
Peer-Reviewed Study in Nature’s Scientific Reports Demonstrates Stem Cell Therapy Promotes Improved Walking and Urinary Function CLEVELAND, Nov. 19, 2015 (GLOBE NEWSWIRE) -- Athersys,...
Athersys Reports Third Quarter 2015 Results
05. November 2015 16:03 ET
|
Athersys, Inc.
CLEVELAND, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial results for the three months ended September 30, 2015. Highlights of the third quarter of...
Athersys Updates on Development Strategy in Japan
21. Oktober 2015 06:30 ET
|
Athersys, Inc.
CLEVELAND, Oct. 21, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (“Athersys”) (NASDAQ:ATHX) announced today that Athersys and Chugai Pharmaceutical Co., Ltd. (“Chugai”) have ended the license...
Athersys to Host Third Quarter Financial Results Call
12. Oktober 2015 15:00 ET
|
Athersys, Inc.
CLEVELAND, Oct. 12, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2015 financial results at approximately 4:00 PM EST on Thursday, November 5, 2015, and...
Athersys to Present at 2015 Stem Cell Meeting on the Mesa
02. Oktober 2015 10:30 ET
|
Athersys, Inc.
CLEVELAND, Oct. 02, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will present at the annual Partnering Forum, part of the Stem...
Athersys Reports Second Quarter 2015 Results
06. August 2015 16:05 ET
|
Athersys, Inc.
CLEVELAND, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) today announced its financial and operating results for the three months ended June 30, 2015. Highlights of the second...